These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26085928)

  • 21. Formulations for modulation of protein release from large-size PLGA microparticles for tissue engineering.
    Qodratnama R; Serino LP; Cox HC; Qutachi O; White LJ
    Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():230-6. PubMed ID: 25492193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells.
    Intra J; Salem AK
    J Drug Target; 2011 Jul; 19(6):393-408. PubMed ID: 20681752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed release of chemokine CCL25 with bioresorbable microparticles for mobilization of human mesenchymal stem cells.
    Fröhlich K; Hartzke D; Schmidt F; Eucker J; Gurlo A; Sittinger M; Ringe J
    Acta Biomater; 2018 Mar; 69():290-300. PubMed ID: 29408710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and characterization of poly(propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles for pH-dependent membrane disruption and cytosolic delivery.
    Fernando LP; Lewis JS; Evans BC; Duvall CL; Keselowsky BG
    J Biomed Mater Res A; 2018 Apr; 106(4):1022-1033. PubMed ID: 29164777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.
    Luan X; Bodmeier R
    J Control Release; 2006 Jan; 110(2):266-272. PubMed ID: 16300851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporation of fast dissolving glucose porogens and poly(lactic-co-glycolic acid) microparticles within calcium phosphate cements for bone tissue regeneration.
    Smith BT; Lu A; Watson E; Santoro M; Melchiorri AJ; Grosfeld EC; van den Beucken JJJP; Jansen JA; Scott DW; Fisher JP; Mikos AG
    Acta Biomater; 2018 Sep; 78():341-350. PubMed ID: 30075321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Issues in long-term protein delivery using biodegradable microparticles.
    Ye M; Kim S; Park K
    J Control Release; 2010 Sep; 146(2):241-60. PubMed ID: 20493221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio.
    Klose D; Siepmann F; Willart JF; Descamps M; Siepmann J
    Int J Pharm; 2010 Jan; 383(1-2):123-31. PubMed ID: 19748558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release.
    Liang D; Frank S; Schwendeman SP
    Drug Deliv Transl Res; 2024 Mar; 14(3):696-704. PubMed ID: 38038895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells.
    Jilek S; Ulrich M; Merkle HP; Walter E
    Pharm Res; 2004 Jul; 21(7):1240-7. PubMed ID: 15290866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres.
    Beig A; Feng L; Walker J; Ackermann R; Hong JKY; Li T; Wang Y; Qin B; Schwendeman SP
    Mol Pharm; 2020 Nov; 17(11):4141-4151. PubMed ID: 32876463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles.
    Lu L; Stamatas GN; Mikos AG
    J Biomed Mater Res; 2000 Jun; 50(3):440-51. PubMed ID: 10737887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic Analysis of Temperature-Dependent Curcumin Release from Poly(lactic-co-glycolic acid)/Poly(lactic acid) Polymer Nanoparticles.
    Sunazuka Y; Ueda K; Higashi K; Wada K; Moribe K
    Mol Pharm; 2024 Mar; 21(3):1424-1435. PubMed ID: 38324797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.
    Mallardé D; Boutignon F; Moine F; Barré E; David S; Touchet H; Ferruti P; Deghenghi R
    Int J Pharm; 2003 Aug; 261(1-2):69-80. PubMed ID: 12878396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donepezil accelerates the release of PLGA microparticles via catalyzing the polymer degradation regardless of the end groups and molecular weights.
    Quan P; Guo W; LinYang ; Cun D; Yang M
    Int J Pharm; 2023 Feb; 632():122566. PubMed ID: 36586633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Roles of the Glass Transition Temperature of PLGA Microparticles in Drug Release Kinetics.
    Park K; Otte A; Sharifi F; Garner J; Skidmore S; Park H; Jhon YK; Qin B; Wang Y
    Mol Pharm; 2021 Jan; 18(1):18-32. PubMed ID: 33331774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites.
    Hedberg EL; Tang A; Crowther RS; Carney DH; Mikos AG
    J Control Release; 2002 Dec; 84(3):137-50. PubMed ID: 12468217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization.
    Kim J; Lima E Silva R; Shmueli RB; Mirando AC; Tzeng SY; Pandey NB; Ben-Akiva E; Popel AS; Campochiaro PA; Green JJ
    Acta Biomater; 2019 Oct; 97():451-460. PubMed ID: 31374338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic explanation of the (up to) 3 release phases of PLGA microparticles: Monolithic dispersions studied at lower temperatures.
    Tamani F; Bassand C; Hamoudi MC; Siepmann F; Siepmann J
    Int J Pharm; 2021 Mar; 596():120220. PubMed ID: 33486018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioactive Hybrid Particles from Poly(D,L-lactide-co-glycolide) Nanoparticle Stabilized Lipid Droplets.
    Joyce P; Whitby CP; Prestidge CA
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17460-70. PubMed ID: 26181279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.